Diamyd Medical’s associated company Cellaviva is appointed European distributor for StemBioSys

Diamyd Medical (Nasdaq Stockholm First North, Ticker: DMYD B) today announced that its associated company Cellaviva AB has signed an agreement regarding the European distribution rights for a stem cell product developed by StemBioSys, Inc., a privatetly held biomedical company based in San Antonio, Texas, USA.The agreement entails that Cellaviva becomes the exclusive distributor for StemBioSys’ (www.stembiosys.com) products in Sweden and Denmark with non-exclusive rights covering the rest of Europe. The agreement will initially cover StemBioSys’ cell expansion product BM-HPME®. Future